Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome, affecting multiple endocrine glands. Duodeno-pancreatic neuroendocrine tumors (DP-NET) represent the most frequent type of NET in MEN1. Their prognosis and treatment strategy is debated.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Modica R
Authors: Modica R, Lo Calzo F, De Cicco F, Bottiglieri F, Sciammarella C,
Keywords: neuroendocrine tumor, MEN1 syndrome, duodeno pancreatic tumor.,
Introduction: The somatostatin analogues are a major therapeutic advance in neuroendocrine tumor (NET) treatment and have multiple modulatory effects on the immune system.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Sciammarella C
Authors: Sciammarella C, Grimaldi A, Circelli L, Modica R, Pizza G,
Keywords: cytokines, neuroendocrine, cell,
#1758 Efficacy and Safety of Low Dose Vandetanib in Metastatic Medullary Thyroid Cancer
Introduction: Medullary thyroid cancer (MTC) is an aggressive thyroid malignancy. Vandetanib is a tyrosine kinase inhibitor approved for locally advanced or metastatic MTC, administered orally 300 mg/daily. Diarrhea, hypertension and QT prolongation are common side effects and may require withdrawal or dose reduction.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Modica R
Authors: Modica R, Pizza G, Lo Calzo F, De Cicco F, Sciammarella C,
Keywords: medullary thyroid cancer, tyrosine kinase inhibitor,
Introduction: Zollinger-Ellison syndrome (ZES) can cause severe complications. In multiple endocrine neoplasia type 1 (MEN1) related ZES, surgery has a controversial role and proton pump inhibitors (PPI) are usually first-line therapy, although some concerns regarding long-term use. Somatostatin analogs (SSA) both reduce hypergastrinemia and have an antiproliferative role.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Modica R
Authors: Modica R, Pizza G, Lo Calzo F, De Cicco F, Sciammarella C,
Keywords: somatostatin analogs, MEN1, Zollinger-Ellison syndrome,
Introduction: Chemokine receptor CXCR4 has been shown to signal on mTOR pathway in gastric and renal cancer. CXCR4 interacts with the chemokine CXCL12 to exert proliferative and chemotactic effects.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Sciammarella C
Authors: Sciammarella C, Circelli L, Guadagno E, Tafuto S, Del Basso De Caro M,
Keywords: chemokine, mtor, nets, clinical outcome.,